Notifications
Clear all
Topic starter
18/08/2026 2:29 pm
TL;DR: Healthcare AI programs can satisfy HIPAA and still fail in production when models drift into unsafe or off-policy behaviour, according to ActiveFence. The core governance problem is that static compliance checks do not capture runtime clinical omission, role drift, or safety regressions that change patient risk.
NHIMG editorial — based on content published by ActiveFence: HIPAA Audit Is Just the Start
By the numbers:
- 80% of organisations report their AI agents have already performed actions beyond their intended scope, including accessing unauthorised systems, inappropriately sharing sensitive data, and revealing access credentials.
Questions worth separating out
Q: How should healthcare teams govern AI use that touches patient data?
A: They should start with discovery, then enforce policy at the point of use, and finally require auditability for every consequential interaction.
Q: Why do static audits miss AI safety problems in live workflows?
A: Static audits confirm that controls existed at a point in time, but they do not show how a model behaves when real users, data, and workflow changes arrive.
Q: What breaks when healthcare AI is not monitored continuously?
A: The system can start producing outputs outside its approved role, and those failures may be subtle enough to pass ordinary reviews.
Practitioner guidance
- Map AI workflows to explicit role boundaries Define what each healthcare AI system is authorised to do, which data it may access, and which outputs are out of scope.
- Add runtime behavioural monitoring Monitor deployed AI systems for clinical omission, role drift, and policy bypass after launch.
- Require auditable safety evidence Keep a traceable record of what was tested, what failed, what was blocked, and what changed between releases.
What's in the full article
ActiveFence's full blog covers the operational detail this post intentionally leaves for the source:
- How WonderSuite maps healthcare AI to HIPAA, the EU AI Act, ISO 42001, NIST, and OWASP in one control workflow
- How the testing, runtime protection, and production re-testing layers are structured across the AI lifecycle
- Examples of the behavioural failures the vendor says it detects, including clinical omission, role drift, and security regressions
- How the safety report supports audit preparation and internal governance review
👉 Read ActiveFence's analysis of healthcare AI compliance and production safety →
Healthcare AI governance: are static audits keeping up?
Explore further
18/08/2026 3:17 pm
Behavioural safety is now a governance control, not a model-quality extra. Healthcare AI cannot be managed safely if teams only check whether the data is protected and the policy is documented. The article points to a deeper control problem: runtime behaviour can diverge from approved use even when the deployment passed a static review. Practitioners should treat behavioural assurance as part of identity and access governance for AI-enabled workflows.
A question worth separating out:
Q: Who is accountable when an AI agent takes a harmful action in healthcare?
A: Accountability should remain with the human or team that deployed and authorised the agent, not with the model itself. The organisation needs named ownership, scope definitions, and logs that tie each action to an identity. Without that chain of responsibility, agentic behaviour becomes operationally opaque and difficult to defend in audits or investigations.
👉 Read our full editorial: Healthcare AI compliance misses behavioural risk in production
